Response Rates Among Blacks Double When New Drugs Are Added to Standard Therapy
Blacks have always lagged behind other patient populations in their response to the standard peginterferon and ribavirin therapy, but the treatment gap between blacks and whites may shrink with the introduction of new therapies. Results vary, but overall studies quote a response rate of 28% among blacks and about half that for white patients.
“Some of the most impressive improvements are in African American patients,” said Donald Jensen, MD, professor of medicine and director of the liver center at the University of Chicago. “[In some patients], we’re seeing response rates as high as 50% or more for the first time.”